BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 21738078)

  • 1. Increased incident hip fractures in postmenopausal women with moderate to severe pelvic organ prolapse.
    Pal L; Hailpern SM; Santoro NF; Freeman R; Barad D; Kipersztok S; Barnabei VM; Wassertheil-Smoller S
    Menopause; 2011 Sep; 18(9):967-73. PubMed ID: 21738078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of pelvic organ prolapse and fractures in postmenopausal women: analysis of baseline data from the Women's Health Initiative Estrogen Plus Progestin trial.
    Pal L; Hailpern SM; Santoro NF; Freeman R; Barad D; Kipersztok S; Barnabei VM; Wassertheil-Smoller S
    Menopause; 2008; 15(1):59-66. PubMed ID: 18257143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of bilateral salpingo-oophorectomy at the time of hysterectomy on pelvic organ prolapse: results from the Women's Health Initiative trial.
    Shveiky D; Kudish BI; Iglesia CB; Park AJ; Sokol AI; Lehman AM; Shara N; Howard BV
    Menopause; 2015 May; 22(5):483-8. PubMed ID: 25423323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of weight change on natural history of pelvic organ prolapse.
    Kudish BI; Iglesia CB; Sokol RJ; Cochrane B; Richter HE; Larson J; Hendrix SL; Howard BV
    Obstet Gynecol; 2009 Jan; 113(1):81-88. PubMed ID: 19104363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between pelvic organ prolapse and climacteric symptoms in postmenopausal women.
    Cagnacci A; Palma F; Napolitano A; Xholli A
    Maturitas; 2017 May; 99():73-78. PubMed ID: 28364872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progression and remission of pelvic organ prolapse: a longitudinal study of menopausal women.
    Handa VL; Garrett E; Hendrix S; Gold E; Robbins J
    Am J Obstet Gynecol; 2004 Jan; 190(1):27-32. PubMed ID: 14749630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between hand-grip strength and site-specific risks of major osteoporotic fracture: Results from the Japanese Population-based Osteoporosis Cohort Study.
    Kamiya K; Kajita E; Tachiki T; Ikehara S; Kouda K; Sato Y; Tamaki J; Kagamimori S; Iki M
    Maturitas; 2019 Dec; 130():13-20. PubMed ID: 31706431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Admixture mapping of pelvic organ prolapse in African Americans from the Women's Health Initiative Hormone Therapy trial.
    Giri A; Hartmann KE; Aldrich MC; Ward RM; Wu JM; Park AJ; Graff M; Qi L; Nassir R; Wallace RB; O'Sullivan MJ; North KE; Velez Edwards DR; Edwards TL
    PLoS One; 2017; 12(6):e0178839. PubMed ID: 28582460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hip fracture in postmenopausal women after cessation of hormone therapy: results from a prospective study in a large health management organization.
    Karim R; Dell RM; Greene DF; Mack WJ; Gallagher JC; Hodis HN
    Menopause; 2011 Nov; 18(11):1172-7. PubMed ID: 21775911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between pelvic organ prolapse and bone mineral density in postmenopausal women.
    Lee SW; Cho HH; Kim MR; You YO; Kim SY; Hwang YB; Kim JH
    J Obstet Gynaecol; 2015; 35(5):476-80. PubMed ID: 25325183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does Home Birth Reduce the Risk of Pelvic Organ Prolapse?
    Peker N; Erdem B; Kaban A
    Ginekol Pol; 2018; 89(8):432-36. PubMed ID: 30215462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial.
    Cauley JA; Robbins J; Chen Z; Cummings SR; Jackson RD; LaCroix AZ; LeBoff M; Lewis CE; McGowan J; Neuner J; Pettinger M; Stefanick ML; Wactawski-Wende J; Watts NB;
    JAMA; 2003 Oct; 290(13):1729-38. PubMed ID: 14519707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wrist Fracture and Risk of Subsequent Fracture: Findings from the Women's Health Initiative Study.
    Crandall CJ; Hovey KM; Cauley JA; Andrews CA; Curtis JR; Wactawski-Wende J; Wright NC; Li W; LeBoff MS
    J Bone Miner Res; 2015 Nov; 30(11):2086-95. PubMed ID: 25990562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoprotein(a) plasma levels, bone mineral density and risk of hip fracture: a post hoc analysis of the Women's Health Initiative, USA.
    Haring B; Crandall CJ; Carbone L; Liu S; Li W; Johnson KC; Wactawski-Wende J; Shadyab AH; Gass ML; Kamensky V; Cauley JA; Wassertheil-Smoller S
    BMJ Open; 2019 Apr; 9(4):e027257. PubMed ID: 31023762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional pelvic floor anatomy in Nepali women attending a general gynaecology clinic.
    Turel F; Caagbay D; Dietz HP
    Int Urogynecol J; 2018 Oct; 29(10):1435-1440. PubMed ID: 29270722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of and risk factors for pelvic organ prolapse and lower urinary tract symptoms among women in rural Nepal.
    Lien YS; Chen GD; Ng SC
    Int J Gynaecol Obstet; 2012 Nov; 119(2):185-8. PubMed ID: 22925819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 27-Hydroxycholesterol, an Endogenous SERM, and Risk of Fracture in Postmenopausal Women: A Nested Case-Cohort Study in the Women's Health Initiative.
    Chang PY; Feldman D; Stefanick ML; McDonnell DP; Thompson BM; McDonald JG; Lee JS
    J Bone Miner Res; 2019 Jan; 34(1):59-66. PubMed ID: 30138538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Physical Activity and Fracture Risk Among Postmenopausal Women.
    LaMonte MJ; Wactawski-Wende J; Larson JC; Mai X; Robbins JA; LeBoff MS; Chen Z; Jackson RD; LaCroix AZ; Ockene JK; Hovey KM; Cauley JA;
    JAMA Netw Open; 2019 Oct; 2(10):e1914084. PubMed ID: 31651972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fracture risk increases after diagnosis of breast or other cancers in postmenopausal women: results from the Women's Health Initiative.
    Chen Z; Maricic M; Aragaki AK; Mouton C; Arendell L; Lopez AM; Bassford T; Chlebowski RT
    Osteoporos Int; 2009 Apr; 20(4):527-36. PubMed ID: 18766294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study.
    McClung MR; O'Donoghue ML; Papapoulos SE; Bone H; Langdahl B; Saag KG; Reid IR; Kiel DP; Cavallari I; Bonaca MP; Wiviott SD; de Villiers T; Ling X; Lippuner K; Nakamura T; Reginster JY; Rodriguez-Portales JA; Roux C; Zanchetta J; Zerbini CAF; Park JG; Im K; Cange A; Grip LT; Heyden N; DaSilva C; Cohn D; Massaad R; Scott BB; Verbruggen N; Gurner D; Miller DL; Blair ML; Polis AB; Stoch SA; Santora A; Lombardi A; Leung AT; Kaufman KD; Sabatine MS;
    Lancet Diabetes Endocrinol; 2019 Dec; 7(12):899-911. PubMed ID: 31676222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.